AI Therapy companion ‘replika’ gains traction among lonely students

The young adult mental health outcomes of using a GPT3-enabled chatbot.

Genetic marker predicts gabapentin response in chronic pelvic pain

Women who carry a particular form of a pain gene are more likely to respond well to a common medication used to treat long-term discomfort,

July 15, 2024

Sparsentan Failed to Preserve Kidney Function Over Time in FSGS

PHILADELPHIA — Treatment with sparsentan (Filspari) led to no significant differences in estimated glomerular filtration rate (eGFR) slope compared with irbesartan among patients with focal

November 4, 2023

AstraZeneca secures first BTK approval in first-line mantle cell lymphoma – Pharmaceutical Technology

Calquence is forecast to generate up to $4.7bn in sales by 2030, as per GlobalData intelligence. Credit: Nadezhda Fedrunova via Getty Images. AstraZeneca has received

January 20, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.